New Drugs, Laser Applications In Glaucoma Pipeline Could Enhance Treatment Options

Monday, March 28, 2011

Comments

Ocular Surgery News

A new medical class, additions to an existing class and new laser applications could increase the therapeutic options for glaucoma treatment, a physician said here.

Full Story

Glaucoma Testing Equipment / Glaucoma Products »

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. Bevacizumab (Avastin)
5. All of the above
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

New Drugs, Laser Applications In Glaucoma Pipeline Could Enhance Treatment Options

Comments

Related Categories

Glaucoma Testing Equipment / Glaucoma Products »

Quick Quiz

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

3nethra classic Ophthalmic Imaging Device

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us